BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Biotech Bay

  Osseon Therapeutics, Inc. Receives Second Patent Allowance for Minimally Invasive Vertebral Compression Fracture Treatment Devices

  October 5, 2010

   · 

  1 min read
• Business

  Eli Lilly and Company Confirms Date and Conference Call for Third-Quarter 2010 Financial Results Announcement

  October 5, 2010

   · 

  1 min read
• BioCapital

  Montgomery College Hosts Lecture About the Importance of Plant Biology

  October 5, 2010

   · 

  1 min read
• Policy

  Novartis AG Sees $590 Million Charge Because of Drug Trial Stoppages for Antifungal Agent Mycograb as Well as Zalbin

  October 5, 2010

   · 

  1 min read
• Business

  NGM Biopharmaceuticals, Inc. Names William J. Rieflin Chief Executive Officer and Director

  October 5, 2010

   · 

  2 min read
• Business

  ModeRNA, Stealth Startup Backed By Flagship VentureLabs, Unveils New Way to Make Stem Cells

  October 5, 2010

   · 

  1 min read
• Drug Development

  Akebia Announces Positive Results for Kidney Disease Drug AKB-6548 Phase 2a Clinical Study

  October 5, 2010

   · 

  3 min read
• Deals

  Feds Force Synthes, Inc. to Sell Norian Corporation, Pay $23 Million in Fines

  October 5, 2010

   · 

  1 min read
• Drug Development

  Celldex Therapeutics, Inc. Brain Cancer Vaccine Doubles Survival in Midstage Trial at Duke University and University of Texas MD Anderson Cancer Center

  October 5, 2010

   · 

  1 min read
• Policy

  Human Genome Sciences, Inc., Novartis Corporation Halt Development of Hepatitis C Drug Albinterferon Alfa-2b After Receiving FDA Letter

  October 5, 2010

   · 

  1 min read